Elsa Arribas, M.D.

Peer-Reviewed Articles

1. Kuerer, HM, Valero, V, Smith, BD, Krishnamurthy, S, Diego, EJ, Johnson, HM, Lin, Y, Shen, Y, Lucci, A, Shaitelman, SF, Mitchell, MP, Boughey, JC, White, RL, Hunt, KK, Yang, WT, Rauch, GM, Moseley, T, Leung, J, Huang, ML, Candelaria, RP, Adrada, BE, Arribas, E, van la Parra, RF, Ramirez, DL, Teshome, M, Hwang, RF, Miggins, MV, Piotrowski, MJ, Correa Refinetti, AP, Ehlers II, RA, Mouabbi, JA, Colen, JS, Loveland-Jones, C, Lesnikowski, BA, Samiian, L, Chong, C, Black, DM, Desyder, SM, Sun, SX, Nguyen, TM. Selective Elimination of Breast Surgery for Invasive Breast Cancer A Nonrandomized Clinical Trial. JAMA Oncology 11(5):529-534, 2025. e-Pub 2025. PMID: 40152443.
2. Guirguis, MS, Arribas, E, Kapoor, MM, Patel, MM, Perez, F, Nia, ES, Ding, Q, Moseley, T, Adrada, BE. Multimodality Imaging of Benign and Malignant Diseases of the Nipple-Areolar Complex. Radiographics 44(4), 2024. e-Pub 2024. PMID: 38483829.
3. Guirguis MS, Arribas EM, Kapoor MM, Patel MM, Perez F, Nia, ES, Ding Q, Moseley TW, Adrada BE. Multimodality imaging of benign and malignant pathologies of the nipple areolar complex. Radiographics 44(4), 2024. e-Pub 2024.
4. Tappa K, Bird JE, Arribas EM, Santiago L. Multimodality imaging for 3D printing and surgical rehearsal in complex spine surgery. Radiographics 44(3):e230116, 2024. e-Pub 2024. PMID: 38386600.
5. Ryan JR, Ghosh R, Sturgeon G, Ali A, Arribas E, Braden E, Chadalavada, Chepelev L, Decker S, Huang Y, Ionita C, Lee J, Liacouras P, Parthasarathy, Ravi P, Sandelier M, Sommer K, Wake N, Rybicki F, Ballard D. Clinical situations for which 3D printing is considered an appropriate representation or extension of data contained in a medical imaging examination: pediatric congenital heart disease conditions. 3D Print Med 10(1), 2024. e-Pub 2024. PMID: 38282094.
6. Adrada, BE, Moseley, T, Kapoor, MM, Scoggins, ME, Patel, MM, Perez, F, Nia, ES, Khazai, L, Arribas, E, Rauch, GM, Guirguis, MS. Triple-Negative Breast Cancer. Radiographics 43(10), 2023. e-Pub 2023. PMID: 37792593.
7. Adrada BE, Moseley TW, Kapoor MM, Scoggins ME, Patel MM, Perez F, Nia ES, Khazai L, Arribas E, Rauch GM, Guirguis MS. Triple-Negative breast cancer: A review of histopathology, genomics, and treatment. RadioGraphics 43(10), 2023. e-Pub 2023. PMID: 3779293.
8. Johnson HM, Lin H, Shen Y, Diego EJ, Krishnamurthy S, Yang WT, Smith BD, Valero V, Lucci A, Sun SX, Shaitelman SF, Mitchell MP, Boughey JC, White RL, Rauch GM, Kuerer HM, Moseley TW, Leung JW, Huang M, Candelaria RP, Adrada BE, Arribas E. Patient-reported outcomes of omission of breast surgery following neoadjuvant systemic therapy a nonrandomized clinical trial. JAMA Network Open 6(9), 2023. e-Pub 2023. PMID: 37707811.
9. Weaver OO, Yang WT, Scoggins ME, Adrada BE, Arribas E, Moseley T, Esquivel J, Melgar Y, Kornecki A. Challenging contrast-enhanced mammography-guided biopsies: Practical approach using real-time multimodality imaging and a proposed procedural algorithm. American Journal of Roentgenology 220(4):512-523, 2023. e-Pub 2023. PMID: 36321982.
10. Arribas EM, Kelil T, Santiago L, Ali A, Chadalavada SC, Chepelev L, Ghodadra A, Ionita CN, Lee J, Ravi P, Ryan JR, Sheikh AM, Rybicki FJ, Ballard DH. Radiological Society of North America (RSNA) 3D Printing Special Interest Group (SIG) clinical situations for which 3D printing is considered an appropriate representation or extension of data contained in a medical imaging examination: breast conditions. 3D Print Med 23:9(1):8, 2023. e-Pub 2023. PMID: 36952139.
11. Kuerer, HM, Smith, B, Krishnamurthy, S, Yang, WT, Valero, V, Shen, Y, Lin, Y, Lucci, A, Boughey, JC, White, RL, Diego, EJ, Rauch, GM, Moseley, T, van la Parra, RF, Adrada, BE, Leung, J, Sun, SX, Teshome, M, Miggins, MV, Hunt, KK, DeSnyder, SM, Ehlers II, RA, Hwang, RF, Colen, JS, Arribas, E, Samiian, L, Lesnikoski, BA, Piotrowski, MJ, Bedrosian, I, Chong, CD, Correa Refinetti, AP, Huang, ML, Candelaria, RP, Loveland-Jones, C, Mitchell, MP, Shaitelman, SF. Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy. The lancet oncology 23(12):1517-1524, 2022. e-Pub 2022. PMID: 36306810.
12. Kuerer HM, Smith BD, Krishnamurthy S, Yang WT, Valero V, Shen Y, Lin H, Lucci A, Boughey JC, White RL, Diego EJ, Rauch GM, on behalf of the Exceptional Responders Clinical Trials Group: Moseley TW, Parra R, Adrada BE, Leung JWT, Sun SX, Teshome M, Miggins MV, Hunt KK, DeSnyder SM, Ehlers RA, Hwang RF, Colen JS, Arribas E, Samiian L, Lesnikoski B, Piotrowski M, Bedrosian I, Chong C, Refinetti AP, Huang M, Candelaria RP, Loveland-Jones C, Mitchell MP, Shaitelman SF. Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: A multicentre, single-arm, phase 2 trial. The Lancet Oncology 23(12):1517-1524, 2022. e-Pub 2022.
13. Huang ML, Hess K, Ma J, Santiago L, Scoggins ME, Arribas E, Adrada BE, Le-Petross HT, Leung JWT, Yang W, Geiser W, Candelaria RP. Prospective comparison of synthesized mammography with DBT and full-field digital mammography with DBT uncovers recall disagreements that may impact cancer detection. Academic Radiology 29(7):1039-1045, 2022. e-Pub 2021. PMID: 34538550.
14. Candelaria RP, Adrada BE, Lane DL, Rauch GM, Moulder SL, Thompson AM, Bassett RL, Arribas EM, Le-Petross HT, Leung JWT, Spak DA, Ravenberg EE, White JB, Valero V, Yang WT. Mid-treatment ultrasound descriptors as qualitative imaging biomarkers of pathologic complete response in patients with triple-negative breast cancer. Ultrasound in Medicine and Biology 48(6):1010-1018, 2022. e-Pub 2022. PMID: 35300879.
15. Musall BC, Abdelhafez AH, Adrada BE, Candelaria RP, Mohamed RMM, Boge M, Le-Petross H, Arribas E, Lane DL, Spak DA, Leung JWT, Hwang KP, Son JB, Elshafeey NA, Mahmoud HS, Wei P, Sun J, Zhang S, White JB, Ravenberg EE, Litton JK, Damodaran S, Thompson AM, Moulder SL, Yang WT, Pagel MD, Rauch GM, Ma J. Functional tumor volume by fast dynamic contrast-enhanced MRI for predicting neoadjuvant systemic therapy response in triple-negative breast cancer. Journal of Magnetic Resonance Imaging 54(1):251-260, 2021. e-Pub 2021. PMID: 33586845.
16. Santiago L, Volk RJ, Checka CM, Black D, Lee J, Colen JS, Akay C, Caudle A, Kuerer H, Arribas EM. Acceptability of 3D-printed breast models and their impact on the decisional conflict of breast cancer patients: A feasibility study. Journal of Surgical Oncology 123(5):1206-1214, 2021. e-Pub 2021. PMID: 33577715.
17. Guirguis MS, Adrada B, Santiago L, Candelaria R, Arribas E. Mimickers of breast malignancy: Imaging findings, pathologic concordance and clinical management. Insights Imaging 12(53), 2021. e-Pub 2021.
18. Nia ES, Adrada BE, Whitman GJ, Candelaria RP, Krishnamurthy S, Bassett RL, Arribas E. MRI features of pseudoangiomatous stromal hyperplasia with histopathological correlation. The Breast Journal 27(3):242-247, 2021. e-Pub 2021.
19. Roy M, Teshome M, Damodaran S, Sahin AA, Khazai L, Arribas E, Candelaria RP, Scoggins ME, Lane DL, Giordano SH, Albarracin CT, Prieto VG, Nagarajan P. Male mammary paget disease: A tale of 2 contrasting cases. The American Journal of Dermatopathology 42(12):981-985, 2020. e-Pub 2020. PMID: 33289978.
20. Candelaria RP, Adrada BE, Hess K, Santiago L, Lane DL, Thompson AM, Moulder SL, Huang ML, Arribas EM, Rauch GM, Leung JWT, Symmans WF, Valero V, Ravenberg EE, White JB, Yang WT. Axillary ultrasound during neoadjuvant systemic therapy in triple-negative breast cancer patients. European Journal of Radiology 130:109170, 2020. e-Pub 2020. PMID: 32777736.
21. Carr LW, Roberts J, Mericli AF, Liu J, Arribas EM, Clemens MW. Breast implant imaging surveillance among US plastic surgeons: FDA recommendations versus clinical reality. Plastic and Reconstructive Surgery 145(6):1381-1387, 2020. e-Pub 2020.
22. DeFazio MV, Arribas EM, Ahmad FI, Le-Petross HT, Liu J, Chu CK, Santiago L, Clemens MW. Application of three-dimensional printed vascular modeling as a perioperative guide to perforator mapping and pedicle Dissection during abdominal flap harvest for breast reconstruction. Journal of Reconstructive Microsurgery 36(5):325-338, 2020. e-Pub 2020. PMID: 32000277.
23. Ballard DH, Sheikh AM, Weadock WJ, Ryan JR, Matsumoto JS, Souza C, Wake N, Levine D, Ghodadra A, Quigley EP, Christensen A, Chepelev L, Althobaithy W, Jeyaraj S, Krivaniak A, Pietila T, Shorti R, Santiago L, Arribas E, Decker S, Parthasarathy J, Witowski J. Radiological Society of North America (RSNA) 3D printing special interest group (SIG) clinical situations for which 3D printing is considered an appropriate representation or extension of data contained in a medical imaging examination: Abdominal, hepatobiliary, and gastrointestinal conditions. 3D Printing in Medicine, 2020. e-Pub 2020.

Review Articles

1. Moseley TW, Adrada BE, Arribas EM, Urban MW, Hesley G, Whitman GJ, Rauch RA, Guirguis MS, Kapoor MM, Lee CU. Selection of breast biopsy markers: effect on breast imaging procedures, follow-up, and costs. Radiographics 46(9), 2026. e-Pub 2026. PMID: 42594023.
2. Rybicki FJ, Arribas EM, Atala A, Ballard DH, Chepelev LL, Decker SJ, Ford J, Ghazi A, Gomez ED, Najm HK, Noël PB, Morris JM, Weber SC, Zablah JE. Medical 3-D printing within a health care facility. J Am Coll Radiol 23(8):1533-1546, 2026. e-Pub 2026.
3. Moseley TW, Adrada BE, Arribas EM, Chung HL, Kapoor MM, Patel MM, Ghannam S, Guirguis MS. Solitary dilated ducts 2.0 - multimodality imaging detection, assessment, and management. J Breast Imaging 7(5):606-618, 2025. e-Pub 2025. PMID: 40884407.
4. Patel, MM, Adrada, BE, Nia, ES, Kapoor, MM, Khazai, L, Guirguis, MS, Perez, F, Moseley, T, Arribas, E. Multimodality imaging of breast cancer recurrence post breast conservation therapy. Current Radiology Reports 12(2):9-18, 2024. e-Pub 2024.
5. Lee J, Chadalavada SC, Ghodadra A, Ali A, Arribas EM, Chepelev L, Ionita CN, Ravi P, Ryan JR, Santiago L, Wake N, Sheikh AM, Rybicki FJ, Ballard DH. Clinical situations for which 3D Printing is considered an appropriate representation or extension of data contained in a medical imaging examination: vascular conditions. 3D Print Med 9(1):34, 2023. e-Pub 2023. PMID: 38032479.
6. Guirguis, MS, Adrada, BE, Santiago, L, Candelaria, RP, Arribas, E. Mimickers of breast malignancy. Insights into Imaging 12(1), 2021. e-Pub 2021. PMID: 33877461.
7. Abdelhafez AH, Musall BC, Adrada BE, Hess K, Son JB, Hwang KP, Candelaria RP, Santiago L, Whitman GJ, Le-Petross HT, Moseley TW, Arribas E, Lane DL, Scoggins ME, Leung JWT, Mahmoud HS, White JB, Ravenberg EE, Litton JK, Valero V, Wei P, Thompson AM, Moulder SL, Pagel MD, Ma J, Yang WT, Rauch GM. Tumor necrosis by pretreatment breast MRI: Association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC). Breast Cancer Research Treatment 185(1):1-12, 2021. e-Pub 2020. PMID: 32920733.

Professional Educational Materials

1. Abouharb S, Adrada B, Akay C, Albarracin C, Arribas E, Arun BK, Barcenas C, Bast RC, Bedrosian I, Booser DJ. Breast Cancer – Metastatic Disease. The University of Texas MD Anderson Cancer Center, 2024.
2. Albarracin C, Dm A, Arribas E, et al. Phyllodes Tumor. University of Texas MD Anderson Cancer Center, 2023.
3. Adrada B, Arribas E, LePetross H, Moseley T, Yang WT. Breast cancer invasive stage I-III, 2023.
4. Adrada B, Arribas E, Huan M, Le-Petross H, Leung J, Moseley T, Scoggins M, Whitman G, Yang WY. Breast cancer ductal carcinoma in situ (DCIS), 2023.
5. Abouharb S, Adrada B, Akay C, Albarracin C, Arribas E, Arun BK, Barcenas C, Bast RC, Bedrosian I, Booser DJ. Cancer Treatment Algorithm, Breast Cancer - Metastatic Disease algorithm. The University of Texas MD Anderson Cancer Center, 2022.
6. Abouharb S, Adrada B, Akay C, Albarracin C, Arribas E, Arun B, Barcenas C, Bast R, Bedrosian I, Black S. Cancer treatment algorithms, Breast cancer- invasive stage I-III. The University of Texas MD Anderson Cancer Center, 2021.
7. Abouharb S, Adrada B, Akay C, Albarracin C, Arribas E, Arun B, Barcenas C, Bast R, Bedrosian I, Booser D. Cancer treatment algorithms, Breast cancer- noninvasive. The University of Texas MD Anderson Cancer Center, 2021.
8. Albarracin C, Araujo D, Arribas E, Arun B, Bevers T, Bast R, Bedrosian I, Benjamin R, Booser D, Brewster A. Cancer treatment algorithms, Phyllodes Tumor. The University of Texas MD Anderson Cancer Center, 2021.

Other Articles

1. Unknown 3D-Printed models help support patient decision making. Radiological Society of North America News, 2021.

Abstracts

1. Rauch GM, Kuerer HM, Adrada BE, Yang WT, Guirguis MS, Patel MM, Arribas EM, Kapoor MM, Nia ES, Moseley TW. Less is more: de-escalation of surgery in the breast and axilla - the role of imaging. Radiological Society of North America Scientific Assembly and Annual Meeting, 2024. e-Pub 2024.
2. Moseley TW, Adrada BE, Whitman GJ, Patel MM, Kapoor MM, Guirguis MS, Arribas EM, Lee CU. Chosen: The impact of breast biopsy marker (CLIP) selection of breast imaging procedures, follow-up, and costs. Radiological Society of North America Scientific Assembly and Annual Meeting, 2024. e-Pub 2024.
3. Arribas EM, Adrada BE, Guirguis MS, Rauch GM, Nia ES, Moseley TW, Kapoor MM, Patel MM. Beyond metastatic lymphadenopathy in breast cancer: an approach to axillary masses. Radiological Society of North America Scientific Assembly and Annual Meeting, 2024. e-Pub 2024.
4. Guirguis MS, Patel MM, Kapoor MM, Moseley TW, Arribas EM, Nia ES, Rauch GM, Adrada BE. Breast Imaging of patients with li-fraumeni syndrome with updated review of breast screening guidelines. Radiological Society of North America Scientific Assembly and Annual Meeting, 2024. e-Pub 2024.
5. Rauch R, Guirguis M, Kapoor M, Arribas E, Adrada B, Whitman G, Moseley T. Sanguis (cruor) pollicetur gloriam: hematologic diseases of the breast - diagnostic features and morphologic mimics. American Roentgen Ray Society Annual Meeting, 2024. e-Pub 2024.
6. Patel M, Sweeney K, Perez, F, Kapoor MM, Guirguis MS, Nia ES, Arribas EM, Moseley TW, Adrada BE. The Many Faces of Invasive Lobular Carcinoma. Radiological Society of North America 109th Annual Meeting, 2023. e-Pub 2023.
7. Nia ES, Kapoor M, Guirguis M, Perez, F, Adrada B, Moseley T, Arribas E, Patel M. Gadgets and gizmos a-plenty: Foreign bodies encountered in breast imaging. 2023 Society of Breast Imaging/American College of Radiology Breast Imaging Symposium, 2023. e-Pub 2023.
8. Kapoor MM, Arribas E, Guirguis MS, Sweeney KJ, Perez F, Nia ES, Patel MM, Adrada BE, Moseley TW. More than just gynecomastia: Spectrum of male breast pathologies. 2023 Society of Breast Imaging/American College of Radiology Breast Imaging Symposium, 2023. e-Pub 2023.
9. Arribas E, Tappa K, Betancourt S, Santiago L, Rice D, Vaporciyan A. 3D printing in complex thoracic surgery. 123rd American Roentgen Ray Society Annual Scientific Abstract Program, 2023. e-Pub 2023.
10. Kapoor M, Patel M, Nia E, Perez F, Arribas E, Adrada B, Moseley T. High-risk benign lesions of the breast: What we can learn from global management strategies. 123rd American Roentgen Ray Society Annual Meeting, 2023. e-Pub 2023.
11. Adrada B, Mosely T, Arribas E, Patel M, Nia E, Kapoor M, Guirguis M. Li fraumeni syndrome: Imaging spectrum and updated breast screening guidelines. 123rd American Roentgen Ray Society Annual Meeting, 2023. e-Pub 2023.
12. Johnson HM, Smith BD, Rauch GM, Krishnamurthy S, Yang WT, Valero V, Shen Y, Lin H, Lucci A, Boughey JC, White RL, Diego EJ, Moseley TW, Leung JWT, Huang M, Candelaria RP, Adrada BE, Arribas E, Parra R, Hunt KK, Bedrosian I, Teshome M, Sun SX, Hwang RF, Miggins MV, Piotrowski M, Refinetti AP, Ehlers RA, Colen JS, Loveland-Jones C, Lesnikowski BA, Samiian L, Chong C, Shaitelman SF, Mitchell MP, Kuerer HM. Eliminating breast surgery for invasive cancer following neoadjuvant systemic therapy (NST): Prospective multicenter clinical trial first planned feasibility report. Western Surgical Association 2022 Annual Meeting, 2022. e-Pub 2022. PMID: 36856291.
13. Perez F, Arribas E, Nia E, Guiguis M, Kapoor M, Patel MM, Adrada B, Moseley T. A comprehensive look at disparities in breast cancer in the non-hispanic black, hispanic and transgender community in the United States and what policy changes should be considered. Radiological Society of North America Scientific Assembly and Annual Meeting Program 2022, 2022. e-Pub 2022.
14. Adrada B, Moseley TW, Rauch GM, Patel MM, Perez F, Kapoor MM, Nia ES, Scoggins ME, Khazai L, Arribas E, Guirguis MS. The many faces of triple negative breast cancer. Radiological Society of North America Scientific Assembly Meeting Program 2022, 2022. e-Pub 2022.
15. Patel M, Adrada BE, Nia ES, Kapoor MM, Khazai L, Guirguis MS, Perez F, Moseley TW, Arribas EM. Multimodality imaging of breast cancer recurrence. Radiological Society of North America Scientific Assembly Meeting Program 2022, 2022. e-Pub 2022.
16. Guirguis MS, Moseley TW, Ding Q, Nia ES, Patel M, Perez F, Kapoor MM, Arribas EM, Adrada BE. All roads lead to Rome: multi-modality imaging of benign and malignant pathologies if the nipple areolar complex. Radiological Society of North America Scientific Assembly Meeting Program 2022, 2022. e-Pub 2022.
17. Moseley TW, Perard R, Guirguis MS, Patel MM, Nia ES, Perez F, Arribas EM, Monetto FP, Adrada BE. Moving beyond alphabet soup using root cause analysis (RCA) and failure mode and effects analysis (FMEA) to learn from errors in the breast imaging clinic. Radiological Society of North America Scientific Assembly Meeting Program 2022, 2022. e-Pub 2022.
18. Santiago L, Tappa K, Arribas EM, Bird JE. 3D printing & surgical rehearsal in complex spine surgery. North America Scientific Assembly and Annual Meeting Program 2022, 2022. e-Pub 2022.
19. Weaver O, Scoggins ME, Adrada BE, Arribas E, Yang WT. Digital breast tomosynthesis combined with contrast-enhanced spectral mammography helps reveal anatomic causes of artifacts and benign enhancing findings on subtracted contrast images. European Society of Radiology 2022 Book of Abstracts as a Supplement to Insights Into Imaging, 2022. e-Pub 2022.
20. Weaver O, Arribas E, Adrada A, Moseley T, Scoggins M. The feasibility of a new built-in specimen radiography solution for the optimization of stereotactic breast biopsy workflow. Radiological Society of North America Scientific Assembly and Annual Meeting, 2021. e-Pub 2021.
21. Rauch GM, Adrada BE, Candelaria RP, Elshafeey NA, Abdelhafez AH, Musall BC, Sun J, Boge M, Mohamed RMM, Son JB, Zhang S, Leung J, Lane D, Scoggins M, Spak D, Arribas E, Santiago L, Whitman GJ, Le-Petross HT, Moseley TW, White JB, Ravenberg E, Hwang K, Wei P, Huo L, Litton JK, Valero V, Tripathy D, Thompson AM, Pagel MD, Ma J, Yang WT, Moulder S. Volumetric changes on longitudinal dynamic contrast enhanced MR imaging (DCE-MRI) as an early treatment response predictor to neoadjuvant systemic therapy (NAST) in triple negative breast cancer (TNBC) patients. San Antonio Breast Cancer Symposium, 2020. e-Pub 2020.
22. Elshafeey NA, Adrada BE, Candelaria RP, Abdelhafez AH, Musall BC, Sun J, Boge M, Mohamed RMM, Mahmoud HS, Son JB, Kotrosou A, Zhang S, Leung J, Lane D, Scoggins M, Spak D, Arribas E, Santiago L, Whitman GJ, Le-Petross HT, Moseley TW, White JB, Ravenberg E, Hwang K, Wei P, Litton JK, Huo L, Tripathy D, Valero V, Thompson AM, Moulder S, Yang WT, Pagel MD, Ma J, Rauch GM. Radiomic phenotypes from dynamic contrast-enhanced MRI (DCE-MRI) parametric maps for early prediction of response to neoadjuvant systemic therapy (NAST) in triple negative breast cancer (TNBC) patients. San Antonio Breast Cancer Symposium, 2020. e-Pub 2020.
23. Zhang S, Rauch GM, Adrada BE, Boge M, Mohamed RMM, Abdelhafez AH, Son JB, Sun J, Elshafeey NA, White JB, Lane DL, Leung JWT, Scoggins ME, Spak DA, Arribas E, Ravenberg E, Santiago L, Moseley TW, Whitman GJ, Le-Petross H, Musall BC, Miyoshi M, Wang X, Willis B, Hash S, Kotrotsou A, Wei P, K-P H, Thompson A, Moulder SL, Candelaria RP, Yang W, Ma J, Pagel MD. Assessment of early response to neoadjuvant systemic therapy (NAST) of triple-negative breast cancer (TNBC) using chemical exchange saturation transfer (CEST) MRI: A pilot study. San Antonio Breast Cancer Symposium, 2020. e-Pub 2020.
24. Candelaria R, Adrada B, Lane D, Roland B, Santiago L, Rauch G, Moseley T, Scoggins M, Thompson A, Ravenberg E, White J, Spak D, Le-Petross H, Arribas E, Whitman G, Leung J, Litton J, Mittendorf E, Huo L, Valero V, Moulder S, Yang W. BI-RADS ultrasound lexicon descriptors and tumor-infiltrating lymphocytes in triple negative breast cancer. Radiological Society of North America Scientific Assembly and Annual Meeting, 2020. e-Pub 2020. PMID: 34272161.
25. Zhang S, Rauch G, Adrada B, Boge M, Mohammed R, Yang W, Nlshafeey N, Sun J, Abdelhafez A, Bum Son J, White J, Moseley T, Whitman G, Le-Petross H, Santiago L, Lane D, Leung J, Scoggins M, Spak D, Arribas E, Ravenberg E, Musall B, Miyoshi M, Wang X, Willis B, Hash S, Kotrotsou A, Wei P, Hwang K, Litton J, Thompson A, Moulder S, Candelaria R, Ma J, Pagel M. Assessment of early response to neoadjuvant systemic therapy (NAST) in triple-negative breast cancer (TNBC) using chemical exchange saturation transfer (CEST) MRI: Pilot study. Radiological Society of North America Scientific Assembly and Annual Meeting, Scientific Poster, 2020. e-Pub 2020. PMID: 34477453.
26. Nia E, Adrada B, Whitman G, Candelaria R, Krishnamurthy S, Bassett R, Arribas E. MRI appearance of pseudoangiomatous stromal hyperplasia (PASH) with pathological correlation. Radiological Society of North America Scientific Assembly and Annual Meeting 27(3):242-247, 2020. e-Pub 2020. PMID: 33393706.
27. Zhang S, Rauch G, Adrada B, Abdelhafez A, Bum Son J, Yang W, Sun J, Boge M, Mohamed R, Elshafeey N, White J, Musall B, Moseley T, Whitman G, Le-Petross H, Santiago L, Lane D, Leung J, Scoggins M, Spak D, Arribas E, Ravenberg E, Miyoshi M, Wang X, Kotrotsou A, Pend W, Hwang K, Litton J, Thompson A, Candelaria R, Moulder S, Ma J, Pagel M. Comparison of chemical exchange saturation transfer (CEST) MRI acquisition and analysis for early neoadjuvant systemic therapy (NAST) treatment response assessment in triple negative breast cancer (TNBC). Radiological Society of North America Scientific Assembly and Annual Meeting, Scientific Poster, 2020. e-Pub 2020.
28. Rauch G, Adrada B, Candelaria R, Elshafeey N, Mohamed R, Boge M, Moseley T, Whitman G, Le-Petross H, Santiago L, Lane D, Leung J, Spak D, Valero V, Litton J, Huo L, Tripathy D, Mittendorf E, Thompson A, Arribas E, Scoggins M, Musall B, Kotrotsou A, Sun J, Bum Son J, White J, Zhang S, Hwang K, Wei P, Moulder S, Pagel M, Ma J, Yang W. Longitudinal MR imaging findings in triple negative breast cancer (TNBC) patients undergoing neoadjuvant systemic therapy (NAST) stratified by tumor infiltrating lymphocytes (TIL) levels. Radiological Society of North America Scientific Assembly and Annual Meeting, Scientific Poster, 2020. e-Pub 2020.
29. Elshafeey N, Adrada B, Koreotsou A, Abdelhafez A, Candelaria R, Yang W, Sun J, Mohamed R, Boge M, Mahmoud H, Musall H, Bum Son J, Tripathy D, Santiago L, Thompson A, Valero V, Whitman G, Litton J, Lim B, Le-Petross H, Leung J, Lane D, Arribas E, Spak D, Scoggins M, Moseley T, Ueno N, Zhang S, White J, Moulder S, Hwang K, Wei P, Pagel M, Ma J, Rauch G. Radiomic phenotypes from ultrafast dynamic contrast enhanced (DCE) MRI for prediction of the treatment response to neoadjuvant systemic therapy (NAST) of triple negative breast cancer (TNBC). Radiological Society of North America Scientific Assembly and Annual Meeting, 2020. e-Pub 2020.
30. Kotrotsou A, Elshafeey N, Adrada B, Sun J, Candelaria R, Abdelhafez A, Yang W, Mohamed R, Boge M, Willis B, Musall B, Bum Son J, Zhang S, Thompson A, Tripathy D, Moseley T, Litton J, Whitman G, Le-Petross H, Valero V, Santiago L, Lane D, Lim B, Leung J, Scoggins M, Spak D, Arribas E, White J, Ravenberg E, Cardenas-Rodriguez J, Wei P, Moulder S, Rauch G, Pagel M. Reliability of pharmacokinetic (PK) parameters by DCE-MRI for prediction of neoadjuvant systemic treatment (NAST) response in triple negative breast cancer (TNBC) patients: A comparison of three analysis methods. Radiological Society of North America Scientific Assembly and Annual Meeting, Scientific Poster, 2020. e-Pub 2020.
31. Musall B, Abdelhafez A, Adrada B, Son JB, Candelaria R, Sun J, Yang W, Santiago L, Whitman G, Le-Petross H, Moseley T, Lane D, Leung J, Scoggins M, Spak D, Arribas E, Mahmoud H, White J, Hwang K, Elshafeey N, Mohamed R, Boge M, Kotrotsou A, Zhang S, Damodaran S, Litton J, Valero V, Tripathy D, Thompson A, Wei P, Moulder S, Pagel M, Ma J, Rauch G. Radiomic feature of quantitative apparent diffusion coefficient (ADC) maps from peritumoral regions (PTRs) as predictors of early treatment response to neoadjuvant systemic therapy (NAST) in triple negative breast cancer (TNBC). Radiological Society of North America Scientific Assembly and Annual Meeting, Scientific Poster, 2020. e-Pub 2020. PMID: 35499264.
32. Santiago L, Volk R, Adrada BE, Black S, Checka CM, Arribas EM. Acceptability of 3D printed breast models and their impact on the decisional conflict of breast cancer patients. European Congress of Radiology 123(5):1206-1214, 2020. e-Pub 2020. PMID: 33577715.
33. Guirguis MS, Moseley TW, Scoggins ME, Kapoor MM, Patel MM, Rauch GM, Nia ES, Arribas EM, Krishnamurthy S, Adrada BE. Horses and Zebras: Benign and Malignant causes of regional lymphadenopathy in Breast Imaging Patients. Radiological Society of North America 111th Scientific Assembly and Annual Meeting.